血浆可溶性ST2水平反映急性呼吸衰竭的肺外器官功能障碍并预测结局
该多中心观察性研究纳入5个队列共1432例急性呼吸衰竭患者(863例非COVID、569例COVID-19),检测血浆和下呼吸道标本中的sST2水平。结果显示血浆sST2在非COVID患者中高于COVID-19患者(P<0.05),且比下呼吸道水平高19倍以上,两室间相关性弱。血浆sST2升高与肺外器官功能障碍和高炎症亚表型相关,但与包括低氧血症在内的呼吸指标无关。校正年龄、性别和疾病严重度后,血浆sST2独立预测30天死亡率;纵向测量中,非存活者在危重病前2周内血浆sST2持续升高。
要点
- 血浆sST2独立预测急性呼吸衰竭患者30天死亡率,校正年龄、性别和疾病严重度后仍有统计学意义。
- 血浆sST2水平与非COVID急性呼吸衰竭患者相比COVID-19患者更高(P<0.05)。
- 血浆sST2水平比下呼吸道标本高19倍以上,两室间相关性弱,提示sST2主要来源于全身。
- 血浆sST2升高与肺外器官功能障碍和高炎症亚表型相关,但与呼吸指标(包括低氧血症)无关。
- 纵向测量显示,非存活者在危重病前2周内血浆sST2持续高于存活者。
适用人群与场景
- 急性呼吸衰竭患者,包括非COVID(863例)和COVID-19(569例)病例,来自5个队列。
- 研究为多中心观察性研究,未报告纳入/排除标准细节。
研究设计与关键结果
- 研究类型:观察性研究,多中心队列,共1432例急性呼吸衰竭患者(863例非COVID、569例COVID-19),来自5个队列。
- 血浆sST2水平在非COVID急性呼吸衰竭患者中高于COVID-19患者(P<0.05)。
- 血浆sST2水平比下呼吸道标本高19倍以上,两室间相关性弱。
- 血浆sST2升高与肺外器官功能障碍和高炎症亚表型相关,但与呼吸指标(包括低氧血症)无关。
- 校正年龄、性别和疾病严重度后,血浆sST2独立预测30天死亡率。
- 纵向测量中,非存活者危重病前2周内血浆sST2持续升高,存活者则不然。
证据类型、等级与局限
- 证据类型:多中心观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 血浆sST2可能有助于识别急性呼吸衰竭中与肺外器官功能障碍和高炎症亚表型相关的患者,并预测30天死亡率,但原文未据此给出推荐。
- 原文指出这些发现凸显IL-33/ST2轴作为治疗靶点的潜力,并需进一步研究其在急性呼吸衰竭多器官功能障碍中的作用(作者认为)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Soluble ST2 (sST2), a decoy receptor for the alarmin interleukin-33 (IL-33), has been implicated in adverse clinical outcomes in acute respiratory failure (ARF). We evaluated sST2 distribution across diverse cohorts of patients with different etiologies of ARF, compared plasma and lower respiratory tract (LRT) concentrations, and examined associations with individual organ dysfunction, biological subphenotypes, and outcomes.
DESIGN: Observational study.
SETTING: Multicenter cohorts of ARF patients.
PATIENTS: A total of 1432 ARF patients, including 863 non-COVID and 569 COVID-19 cases, from five cohorts.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: sST2 levels were measured in plasma and LRT specimens (when available) and analyzed for associations with ARF etiology, severity, organ dysfunction, systemic host response, subphenotypes, and 30-day mortality. Plasma sST2 levels were higher in non-COVID ARF patients compared with COVID-19 patients ( p < 0.05) and were markedly elevated compared with LRT levels (> 19-fold), with weak intercompartmental correlation. Elevated plasma sST2 levels were associated with extrapulmonary organ dysfunction and a hyperinflammatory ARF subphenotype but not with respiratory indices, including hypoxemia. Plasma sST2 independently predicted 30-day mortality in pooled cohort data, adjusted for age, sex, and illness severity. In longitudinal measurements, nonsurvivors had persistently elevated plasma sST2 levels in the first 2 weeks of critical illness compared with survivors.
CONCLUSIONS: Plasma sST2 levels independently predict outcomes in ARF and are strongly associated with extrapulmonary organ dysfunction. The weak correlation between plasma and LRT sST2 levels suggests a predominantly systemic source. These findings highlight the potential of the IL-33/ST2 axis as a therapeutic target and warrant further investigation into its role in multiple organ dysfunction in ARF.
参考来源
- Labar AS, Ulrich BC, Lovelace TC, et al. Plasma Levels of Soluble ST2 Reflect Extrapulmonary Organ Dysfunction and Predict Outcomes in Acute Respiratory Failure. Crit Care Med. 2025. PMID: 40402026. doi:10.1097/CCM.0000000000006716
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。